Drug · DIN 02436841
ENTYVIO
FOR I.V. INFUSION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 21, 2015; first marketed April 21, 2015.
- Drug Identification Number (DIN)
- 02436841
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Vedolizumab L04AG05
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VEDOLIZUMAB | 300 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 29, 2015: NOC 16576New Drug Submission (NDS)
Other DINs named ENTYVIO
- DIN 02497867 · Marketed
- DIN 02497875 · Marketed